Author:
Louvet Christophe,de Gramont Aimery
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference16 articles.
1. Raymond E, Faivre S, Woynarowski JM, et al.: Oxaliplatin: mechanism of action and antineoplastic activity. Semin Oncol 1998, 25(Suppl 5):4–12. This article summarizes the main data regarding oxaliplatin, which are useful for the rationale of clinical use.
2. Machover D, Diaz-Rubio E, de Gramont A, et al.: Two consecutive phase II studies of oxaliplatin for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol 1996, 7:95–98.
3. Becouarn Y, Ychou M, Ducreux M, et al.: Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer. J Clin Oncol 1998, 16:2739–2744.
4. Raymond E, Buguet-Fagot C, Djelloul S, et al.: Antitumor activity of oxaliplatin in combination with fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Anticancer Drugs 1997, 8:876–885.
5. Levi F, Zidani R, Misset JL, et al.: Randomised multicenter trial of chronotherapy with oxaliplatin, fluorouracil and folinic acid in metastatic colorectal cancer. Lancet 1997, 3–50:681–686.